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1. Introduction 
The antipsychotic drug trifluoperazine (TFP) is 
known to be an effective inhibitor of the calcium- 
binding activator protein, calmodulin (CaM). It has 
been shown that 2 mol TFP bind to 1 mol CaM with 
Kd - lOA M [ 11. In [2] ‘13Cd NMR was used to study 
the effects of TFP binding to CaM on the cation bind- 
ing sites of the protein. It was found that the binding 
of 2 mol drug to 1 mol protein affected all 4 cation- 
binding sites. 
We have been using high resolution ‘II NMR to 
study the conformation of calmodulin in solution 
under varying conditions. Our observations on the 
protein itself agree with those in [3]. Here we report 
the effects of drug binding on the ‘H NMR spectrum 
of calmodulin. 
2. Materials and methods 
Calmodulin was prepared from bovine brain essen- 
tially by the method in [4]. The purity of the protein 
was checked by polyacrylamide gel electrophoresis, in 
the presence and absence of SDS, and by the ability 
of the protein to activate activator-deficient cyclic 
nucleotide phosphodiesterase. 
Pulsed Fourier transform ‘II NMR spectra were 
monitored using a modified Bruker console, an Oxford 
Instruments superconducting magnet and a Nicolet 
1085 computer at 270 MHz or a Bruker WI1300 spec- 
trometer at 300 MHz. Quadrature detection was used. 
All spectra were obtained at 37°C. The protein solu- 
tions were made up in 5 mM Tris, 0.2 M KCl, pH 7.4 
in DzO. Although we have made a full study of the 
protein on its own we shall not report our assignments 
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of the calmodulin spectrum itself since they agree with 
those in [3]. Methionine resonances which are impor- 
tant in the description of the results were recognised 
as singlet methyl groups in the region of 2.0 ppm. 
3. Results 
3.1. The addition of trifuoperazine to calmodulin 
Aliquots of a 30 mM solution of TFP in DzO were 
successively added to a 2 mM solution of calmodulin 
which was fully bound with calcium ([Ca”] = 10 mM; 
[KC11 = 0.2 M; pH 7.4). Some of our observations 
are shown in fig.1. The continuous shifts of peaks 
with little broadening shows that the system is in fast 
exchange on the NMR time scale. There was little 
effect on the aromatic region of the protein spectrum. 
The most downfield phenylalanine resonance (7.35 
ppm) moved upfield, disappearing under other phenyl- 
alanine resonances at 7.26 ppm on the addition of 
1 mol equiv. TFP. This resonance is associated with 
the weak sites of calcium binding (in preparation). A 
new sharp resonance grew in intensity and first appear- 
ed clearly in the TFP:CaM = 1: 1 spectrum at 6.97 
ppm. The intensity of this peak increased further and 
continuously throughout the titration and shifted 
upfield to 6.70 ppm in the TFP:CaM = 2:l spectrum. 
There was also a continuous increase of intensity at 
around 7.00 ppm and this peak shifted continuously 
upfield to 6.89 ppm during the titration. These two 
resonances are due to the aromatic protons of the 
drug molecule which are centred around 7.20 and 
7.03 ppm in the protein-free drug spectrum. These 
peaks may hide small changes in the protein spectrum. 
The changes to the aliphatic region of the calmod- 
ulin NMR spectrum caused by the drug binding were 
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Fig.1. (A) The aromatic region; (B) thealiphaticregion ofthe convolution difference spectra at 270 MHz: (a) calmodulin; (b) TFP: 
CaM = 1: 1; (c) TFP:CaM = 2.1. Arrows indicate the resonances due to protons of TFP. Chemical shifts are relative to TSS = 0.0 ppm. 
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Fig.2. The chemical shifts of some of the aliphatic resonances 
in the ’ H NMR spectrum of calmodulin during titration with 
TFP binding. 
more dramatic. The affected resonances may be cate- 
gorized into 3 types of behaviour (fig.2): 
(i) Those which changed during the addition of O-1 
mol TFP/mol CaM; 
(ii) Those which changed during the addition of l-2 
mol TFP/mol CaM; 
(iii) Those which changed continuously throughout 
the entire titration. 
In the first half of the drug titration, the following 
observations were made. The most upfield shifted 
absorption peak (0.3 1 ppm) split gradually into two 
peaks. Part of the intensity remained at 0.31 ppm and 
part shifted downfield towards the major methyl peak. 
Three singlet resonances due to the methyl group of 
methionine residues, which are resolved in the drug- 
free spectrum at 1.90, 1.85, and 1.80 ppm, merged 
into a single resonance and at least two of the reso- 
nances titrated uptield to around 1.68 ppm. At the 
same time, intensity was lost from the region of 1.70 
ppm in the drug-free spectrum. This resonance has 
been assigned to the /3-CH2 protons of lysine residues 
(unpublished). In the TFP:CaM = 1: 1 spectrum, both 
the lysine and the methionine resonances at 1.68 ppm 
were somewhat broad. Another singlet resonance from 
a methionine methyl group at 2.00 ppm broadened 
and disappeared from the spectrum. Some smaller 
changes occurred elsewhere in the spectrum. 
During the second half of the drug titration further 
observations were made. A peak appeared upfield of 
the major methyl peak and continued to shift upfield 
to 0.60 ppm. At the same time, part of the major 
methyl peak (0.86 ppm) shifted upfield to 0.76 ppm. 
As that intensity shifted upfield, the residual intensity 
was left behind at 0.90 ppm, so that in the TFP:CaM = 
2:l spectrum there are two large methyl peaks of 
approximately equal intensity. At TFP:CaM > 1, the 
peak at 3.04 ppm due to the &HZ protons of lysine 
residues (unpublished) broadened. 
There were several other resonances which changed 
continuously throughout the whole titration. The 
most dramatic of these was an easily seen methio- 
nine singlet resonance which titrated upfield in fast 
exchange from 2.07-l .7 1 ppm, while a second reso- 
nance, possibly another methionine, moved from 
1.85-1.40 ppm. Two other methionine resonances 
also titrated upfield with smaller shifts of 0.19 and 
0.12 ppm, most of the shifts taking place in the second 
half of the titration. The upfield-shifted methyl reso- 
nances at 0.57 ppm shifted further upfield, joining 
with the resonance from 0.47 ppm to form a sharp 
peak at 0.54 ppm in the 1: 1 spectrum from which, at 
higher TFP:CaM ratios, some intensity shifted down- 
field to 0.60 ppm. A sharp peak appeared at 2.70 ppm 
and grew continuously. This resonance appeared as a 
singlet in the Carr-Purcell spectrum of the drug-pro- 
tein complex and is due to the terminal N-CHa group 
of the drug molecule. In the absence of protein this 
peak appears at 2.76 ppm. 
3.2. Nuclear Overhauser effect difference spectroscopy 
Nuclear Overhauser effect (NOE) difference spec- 
troscopy was performed on the final TFP-CaM com- 
plex. When the methyl resonance at 0.60 ppm was 
irradiated, 3 aromatic resonances howed a negative 
NOE. These were the 2 drug resonances at 6.70 and 
6.89 ppm and 1 protein resonance at 7.05 ppm. When 
the methyl resonance at 0.76 ppm was irradiated, 
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Fig.3. A diagramatic representation of the sequence of calmodulin. Each domain (I-IV) includes an EF hand. All aromatic, methi- 
onine, and lysine residues are marked. The proposed TFP binding sites are noted. 
the 2 drug peaks and a phenylalanine resonance at 
7.19 ppm showed negative NOE. The protein peaks 
observed in these NOE experiments correspond to 
regions in which the protein spectrum changed on 
drug binding. 
4. Discussion 
The NMR titration of calmodulin (CaM) with tri- 
fluoperazine (TFP) has 2 steps which have quite dis- 
tinct effects on the spectra of the protein. This result 
agrees with [ 11, showing that the binding ratio is 2: 1. 
The on/off rate of both drug molecules are fast on 
the NMR time scale and we can state that despite 
strong binding the offrate constant is -lo* s-l which 
compares well with the rate in [2] of -lo3 s-l. 
This NMR study permits us to make certain struc- 
tural conclusions. We do this in the light of a diagram- 
atic representation for calmodulin which has 4 EF 
hands (fig.3) although we are not able to say in what 
order the hands are put together in the folded form. 
The diagram shows the location in the sequence of 
several important residues. 
The first important observation is that there is a 
relatively small effect in most regions of the NMR 
spectrum despite the fact that TFP is an aromatic 
molecule. Certain resonances are totally unaffected; 
including both tyrosines, the trimethyllysine, and 
much of the phenylalanine spectrum. One phenyl- 
alanine is slightly affected however. We concluded that 
there is only a small interaction between the drug and 
any of the aromatic side-chains. The fact that the 
resonances of the drug itself are largely unaltered again 
indicates that it does not come close to the aromatic 
side-chains of the protein; see below. 
The methyl region of the NMR spectrum of the 
protein is grossly affected and very differently by the 
first and second drug molecules. The biggest shifts for 
the binding of the first molecule are on the methio- 
nine (especially marked), one or two ring-current 
shifted methyl resonances, and on lysines. Reference 
to the sequence (fig.3) shows that a possible explana- 
tion lies in binding in the regions of the top of domains 
II or IV. The second drug molecule has a smaller effect 
everywhere in the spectrum except in the unshifted 
methyl group region. Clearly, the aromatic side-chains 
of the protein are not involved, but once again methi- 
onine resonances are greatly altered. We indicate the 
possible parts of the sequence for the binding of the 
second molecule of TFP in fig.3. We note that the 
sequences of domains 2 and 4 are homologous. 
The NOE experiments confirm the studies using 
the shifts of protein resonances. The most striking 
observation is the strong NOE from the upfield shifted 
methyls to the drug aromatic protons. 
Reference to fig.3 shows that the drug-binding 
sites are not close to the calcium-binding sites which 
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are known to carry aromatic residues. The fact that 
For&n et al. (2) observed effects from drug-binding 
upon rr3Cd (in place of calcium) resonances implies 
that the remote binding of the drug relays effects to 
these sites. However the drug does not alter much the 
binding constant for calcium. It would appear that the 
drug binds to a region of the calmodulin involved in 
association with receptor proteins since the methio- 
nine-rich region of calmodulin is near the homologous 
transmission region of troponin C uncovered in [5]. 
Elsewhere we shall report a very similar reaction of 
troponin C with TFP. 
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